Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2026,
Core Laboratories paidMXN72 Mil more to buy back shares than it received from issuing new shares.
It receivedMXN72 Mil from issuing more debt.
It paidMXN0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentMXN8 Mil paying cash dividends to shareholders.
It receivedMXN0 Mil on other financial activities.
In all, Core LaboratoriesspentMXN8 Mil on financial activities for the
three
months ended in Mar. 2026.
Core Laboratories (MEX:CLB) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Core Laboratories's issuance of stock for the
three
months ended in Mar. 2026 was MXN0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Core Laboratories's repurchase of stock for the
three
months ended in Mar. 2026 was MXN-72 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Core Laboratories's net issuance of debt for the
three
months ended in Mar. 2026 was MXN72 Mil.
Core Laboratories receivedMXN72 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Core Laboratories's net issuance of preferred for the
three
months ended in Mar. 2026 was MXN0 Mil.
Core Laboratories paidMXN0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Core Laboratories's cash flow for dividends for the
three
months ended in Mar. 2026 was MXN-8 Mil.
Core Laboratories spentMXN8 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Core Laboratories's other financing for the
three
months ended in Mar. 2026 was MXN0 Mil.
Core Laboratories receivedMXN0 Mil on other financial activities.
Core Laboratories Cash Flow from Financing Related Terms
Core Laboratories Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Core Laboratories's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-499 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of MXN-499 Mil mean?
Core Laboratories (MEX:CLB) has a Cash Flow from Financing of MXN-499 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Core Laboratories and its competitors.
Is Core Laboratories' Cash Flow from Financing too high?
Core Laboratories' current Cash Flow from Financing is MXN-499 Mil. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Cash Flow from Financing compare to EROK and OIS?
Core Laboratories' Cash Flow from Financing of MXN-499 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for an Oil & Gas company?
A good Cash Flow from Financing depends on the Oil & Gas industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Core Laboratories and its competitors. Core Laboratories's current Cash Flow from Financing is MXN-499 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Cash Flow from Financing of MXN-499 Mil. The stock's GF Value™ is MXN1,282.42, compared to a current price of MXN856.38 — trading 33.2% below its estimated fair value. The current Cash Flow from Financing is MXN-499 Mil. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Cash Flow from Financing is MXN-499 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 33.2% below its estimated GF Value™ of MXN1,282.42.
Key valuation signals for MEX:CLB:
Cash Flow from Financing: MXN-499 Mil
GF Value™: MXN1,282.42 vs. price of MXN856.38 (33.2% below fair value)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
